KUALA LUMPUR - The Health Ministry (MOH) has approved the registration of Xenpozyme (Olipudase alfa 20mg), to treat patients suffering from Acid Sphingomyelinase Deficiency (ASMD),.
KUALA LUMPUR, Oct 7 The Ministry of Health (MoH) has approved the registration of Xenpozyme (Olipudase alfa 20mg), to treat patients suffering from Acid Sphingomyelinase.
KUALA LUMPUR (Oct 7): The Ministry of Health (MOH) has approved the registration of Xenpozyme (Olipudase alfa 20mg), to treat patients suffering from Acid Sphingomyelinase Deficiency (ASMD), a rare genetic disease.
Health director-general Datuk Dr Muhammad Radzi Abu Hassan said that the decision
PETALING JAYA: Several commitments, including early notices to healthcare providers over the possible shortage of certain medication, have been agreed between the Association of Private Hospitals Malaysia and Pharmaceutical Association of Malaysia.